Ubrogepant is Effective for the Acute Treatment of Migraine in Patients with an Insufficient Response to Triptans

被引：0
|
作者：
Blumenfeld, Andrew M. [1 ]
Goadsby, Peter J. [2 ]
Dodick, David W. [3 ]
Hutchinson, Susan [4 ]
Liu, Chengcheng [5 ]
Finnegan, Michelle [5 ]
Trugman, Joel M. [5 ]
Szegedi, Armin [5 ]
机构：
[1] Headache Ctr Southern Calif, Neurol Ctr, Carlsbad, CA USA
[2] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[3] Mayo Clin, Phoenix, AZ USA
[4] Orange Cty Migraine & Headache Ctr, Irvine, CA USA
[5] Allergan Plc, Madison, NJ USA
来源：
CEPHALALGIA | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-OR-015
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [1] Ubrogepant is Effective for the Acute Treatment of Migraine in Patients with an Insufficient Response to Triptans
    Blumenfeld, Andrew M.
    Goadsby, Peter J.
    Dodick, David W.
    Hutchinson, Susan
    Liu, Chengcheng
    Finnegan, Michelle
    Trugman, Joel M.
    Szegedi, Armin
    NEUROLOGY, 2019, 92 (15)
  • [2] Ubrogepant Is Effective for the Acute Treatment of Migraine in Patients for Whom Triptans Are Ineffective
    Blumenfeld, A. M.
    Goadsby, P. J.
    Dodick, D. W.
    Hutchinson, S.
    Liu, C.
    Finnegan, M.
    Trugman, J. M.
    Szegedi, A.
    HEADACHE, 2019, 59 : 19 - 19
  • [3] Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the CENTURION Study
    Reuter, Uwe
    Lombard, Louise
    Krege, John
    Krikke-Workel, Judith
    Wilhelm, Stefan
    Kovacik, Amy J.
    Lin, Qun
    Dowsett, Sherie
    Buse, Dawn
    NEUROLOGY, 2021, 96 (15)
  • [4] Lasmiditan is effective in the acute treatment of migraine in patients with insufficient response to triptans: Findings from the CENTURION study
    Lombard, L. A.
    Reuter, U.
    Krege, J. H.
    Krikke-Workel, J.
    Wilhelm, S.
    Kovacik, A. J.
    Lin, Q.
    Dowsett, S.
    Buse, D. C.
    HEADACHE, 2021, 61 : 156 - 156
  • [5] Ergotamine for the treatment of migraine attacks after insufficient response to triptans
    Kinzinger, U.
    Schierstedt, D.
    NERVENHEILKUNDE, 2010, 29 (1-2) : 52 - 56
  • [6] Ubrogepant Is Effective in the Acute Treatment of Migraine With Mild Pain
    Lipton, R. B.
    Dodick, D. W.
    Goadsby, P. J.
    Burstein, R.
    Adams, Manack A.
    Lai, H.
    Yu, S.
    Finnegan, M.
    Trugman, J. M.
    HEADACHE, 2020, 60 : 126 - 126
  • [7] UBROGEPANT IS EFFECTIVE IN THE ACUTE TREATMENT OF MIGRAINE WITH MILD PAIN
    Lipton, Richard B.
    Dodick, David W.
    Goadsby, Peter J.
    Burstein, Rami
    Adams, Aubrey M.
    Lai, Jeff
    Yu, Sung Y.
    Finnegan, Michelle
    Trugman, Joel M.
    CEPHALALGIA, 2020, 40 : 13 - 14
  • [8] Ubrogepant is Effective in the Acute Treatment of Migraine with Mild Pain
    Lipton, Richard
    Dodick, David
    Goadsby, Peter
    Burstein, Rami
    Adams, Aubrey
    Lai, Jeff
    Yu, Sung
    Finnegan, Michelle
    Trugman, Joel
    NEUROLOGY, 2020, 94 (15)
  • [9] Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
    Leroux, Elizabeth
    Buchanan, Andrew
    Lombard, Louise
    Loo, Li Shen
    Bridge, Daisy
    Rousseau, Ben
    Hopwood, Natasha
    Matthews, Brandy R.
    Reuter, Uwe
    ADVANCES IN THERAPY, 2020, 37 (12) : 4765 - 4796
  • [10] Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
    Elizabeth Leroux
    Andrew Buchanan
    Louise Lombard
    Li Shen Loo
    Daisy Bridge
    Ben Rousseau
    Natasha Hopwood
    Brandy R. Matthews
    Uwe Reuter
    Advances in Therapy, 2020, 37 : 4765 - 4796
12345